...依维莫司(Everolimus)是一种可以获得的口服mTOR抑制剂,这种药物已经被批准用来治疗肾细胞癌,胰腺神经内分泌肿瘤,与TSC相关的室管膜下巨细胞星形细胞...
基于1466个网页-相关网页
...药物名称:飞尼妥(everolimus,依维莫司)开发者:诺华药物类别:哺乳动物雷帕霉素靶蛋白(mTOR)抑制剂适应证/试验阶段:肝细胞癌;人表皮生长因子受体2阳性(H...
基于23个网页-相关网页
Everolimus impurity 依维莫司杂质D ; 依维莫司杂质A ; 依维莫司杂质B ; 依维莫司杂质C
Everolimus Tablets 依维莫司片
Everolimus impurity D 依维莫司杂质D
Everolimus impurity B 依维莫司杂质B
Everolimus impurity A 依维莫司杂质A
Everolimus impurity C 依维莫司杂质C
Everolimus-Eluting Stents 涂层支架
Everolimus-d4 依维莫司
Afinitor everolimus 依维莫司
Conclusion: Everolimus can delay the progression of diabetic nephropathy.
结论:依维莫司能够延缓糖尿病肾病的进展。
Severe diarrhea occurred at a higher frequency in the combination group than in the everolimus group.
严重的腹泻在联合用药组的发生率高于依维莫司组。
Because of these safety concerns, a risk evaluation and mitigation strategy has been implemented to educate patients and clinicians regarding the safe use and risks of everolimus.
基于这些安全性的考虑,研究者们正在进行一些危险评估和缓解策略,从而对患者和临床医生进行依维莫司安全使用和危险因素的相关教育。
应用推荐